These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 313319)

  • 1. [The effect of the spleen on tumor growth in mouse lines with various spleen sizes].
    von Wallenberg H; Mainusch P; Meyer J; Hammer C
    Chir Forum Exp Klin Forsch; 1979; ():169-73. PubMed ID: 313319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced tumor growth caused by anti-Th-B antiserum due to a possible activation of suppressor T-cells.
    Kakimoto K; Fuji H; Grossberg AL; Pressman D
    Cancer Res; 1977 Sep; 37(9):3145-50. PubMed ID: 301773
    [No Abstract]   [Full Text] [Related]  

  • 3. [Role of immunologic activity of host in radiotherapy].
    Tsuchiya T
    Gan No Rinsho; 1983 Oct; 29(13):1499-505. PubMed ID: 6608014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of cloned high- and low-metastatic murine Lewis lung tumor cells to lysis by cytotoxic autoreactive cells.
    Olsson L; Kiger N; Kronstrom H
    Cancer Res; 1981 Nov; 41(11 Pt 1):4706-9. PubMed ID: 6975655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological evaluation of splenectomy in tumor-bearing mice].
    Yamagishi H; Naito K; Maeda Y; Kurioka H; Kobayashi M; Fujimori C; Iguchi K; Tanaka T; Hashimoto I
    Nihon Geka Gakkai Zasshi; 1983 Sep; 84(9):987-91. PubMed ID: 6676671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stimulatory effect of tumor bearing upon the T- and B-cell subpopulations of the mouse spleen.
    Konda S; Nakao Y; Smith RT
    Cancer Res; 1973 Oct; 33(10):2247-56. PubMed ID: 4147496
    [No Abstract]   [Full Text] [Related]  

  • 7. A syngeneic metastatic tumor model in mice: the natural immune response of the host and its manipulation.
    Treves AJ; Cohen IR; Feldman M
    Isr J Med Sci; 1976; 12(4-5):369-84. PubMed ID: 1084880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged heart allograft survival resulted from donor-specific T-cell sequestering and removal by selective splenectomy in mice.
    Zhu XH; Chen S; Chen ZK
    Transplant Proc; 2004 Oct; 36(8):2448-9. PubMed ID: 15561276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tumor bearing on the dynamics of host hemopoietic cells.
    Lala PK
    Cancer Treat Rep; 1976 Dec; 60(12):1781-9. PubMed ID: 1026335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
    J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice.
    Fujii T; Igarashi T; Kishimoto S
    J Natl Cancer Inst; 1987 Mar; 78(3):509-17. PubMed ID: 2950265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of T-cells in the mechanism of reactivity of the microplate leukocyte adherence inhibition assay.
    Raina S; Russo AJ; Jenkins D; Goldrosen MH
    Cancer Res; 1981 Oct; 41(10):3950-5. PubMed ID: 6456811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo generation of tumor-specific cytotoxic T-cells in the regional lymph node: effect of subcutaneous inoculation of mls-disparate spleen cells around implanted tumors in mice.
    Higasa M; Yamada K; Takagaki Y; Aoki M; Shinka S; Dohi Y
    Cancer Res; 1986 Oct; 46(10):4991-4. PubMed ID: 3489518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heterogeneity of T-cell populations. Proof of the non-identity of killer T-cells and helper T-cells].
    Khaitov RM; Gambarov SS; Norimov ASh
    Tsitologiia; 1976 Dec; 18(12):1498-1501. PubMed ID: 1088322
    [No Abstract]   [Full Text] [Related]  

  • 15. Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.
    Barker E; Mokyr MB
    Cancer Res; 1988 Sep; 48(17):4834-42. PubMed ID: 3261626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary cytotoxic tumor immune response induced in vitro.
    Röllinghoff M
    J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
    [No Abstract]   [Full Text] [Related]  

  • 17. The early appearance of specific cytotoxic T cells in murine gut mucosa.
    Davies MD; Parrott DM
    Clin Exp Immunol; 1980 Nov; 42(2):273-9. PubMed ID: 6970637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological competence of spleen cells from rats bearing syngeneic or autochthonous tumours.
    Medzihradský J; Koníková E; Novotná L
    Neoplasma; 1972; 19(2):105-10. PubMed ID: 4401919
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of tumour-associated transplantation antigen of BO-IV carcinoma on somatic cells of tumour-free syngeneic mice. I. Demonstration of this antigen on spleen cells.
    Rejthar A
    Folia Biol (Praha); 1972; 18(2):132-8. PubMed ID: 4554741
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of splenectomy upon tumor growth: characterization of splenic tumor-enhancing cells in vivo.
    Yamagishi H; Pellis NR; Kahan BD
    Surgery; 1980 Jun; 87(6):655-61. PubMed ID: 6445603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.